Clinical trial
Impact of Perioperative Dexmedetomidine on Long-term Survival in Older Patients After Cancer Surgery: a Multicenter Randomized Trial
NCT06030804 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Perioperative Dexmedetomidine on Long-term Survival in Older Patients After Cancer Surgery: a Multicenter Randomized Trial
- Lead sponsor
- Peking University First Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 12, 2023
- Completion date
- October 31, 2028
- Enrollment
- 4,532 (estimated)
- Sites
- 39
Conditions
As the registry lists them; a condition with its own page is linked.
cancer surgery, dexmedetomidine, elderly, long-term survivors